A Double-Blind, Randomized, Placebo-Controlled Phase 3 Noninferiority Study of Darbepoetin Alfa for Anemia in Advanced NSCLC

被引：3

作者：

Nagarkar, R. ^{[1
]}

Gascon, P. ^{[2
]}

Smakal, M. ^{[3
]}

Syrigos, K. ^{[4
]}

Barrios, C. ^{[5
]}

Cardenas Sanchez, J. ^{[6
]}

Zhang, L. ^{[7
]}

Tomita, D. ^{[8
]}

Park, J. ^{[8
]}

Brandao, C. De Oliveira ^{[8
]}

机构：

[1] Curie Manavata Canc Ctr, Nasik, Maharashtra, India

[2] Barcelona Univ, Hosp Clin, Barcelona, Spain

[3] Nh Hosp AS, Nemocn Horovice, Horovice, Czech Republic

[4] Athens Sch Med, Dept Med 3, Athens, Greece

[5] Hosp Canc Mae Deus, Med Oncol, Porto Alegre, RS, Brazil

[6] Ctr Med Colima, Colima, Mexico

[7] Sun Yat Sen Univ, Canc Ctr, East Guangzhou, Peoples R China

[8] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

overall survival; darbepoetin alfa; chemotherapy-induced anemia;

D O I：

10.1016/j.jtho.2018.08.325

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA02.05

引用

页码：S359 / S359

页数：1

共 50 条

[41] Interferon alfa-2a in the treatment of Behcet disease - A randomized placebo-controlled and double-blind study
Alpsoy, E
Durusoy, C
Yilmaz, E
Ozgurel, Y
Ermis, O
Yazar, S
Basaran, E
ARCHIVES OF DERMATOLOGY, 2002, 138 (04) : 467 - 471
[42] Pregabalin Does Not Affect Sperm Production in Healthy Volunteers: A Randomized, Double-blind, Placebo-controlled, Noninferiority Study
Sikka, Suresh C.
Chen, Crystal
Almas, Mary
Dula, Eugene
Knapp, Lloyd E.
Hellstrom, Wayne J. G.
PAIN PRACTICE, 2015, 15 (02) : 150 - 158
[43] Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure - A randomized, double-blind, placebo-controlled trial
Ponikowski, Piotr
Anker, Stefan D.
Szachniewicz, Joanna
Okonko, Darlington
Ledwidge, Mark
Zymlmski, Robert
Ryan, Enda
Wasserman, Scott M.
Baker, Nigel
Rosser, Dylan
Rosen, Stuart D.
Poole-Wilson, Philip A.
Banasiak, Waldemar
Coats, Andrew J. S.
McDonald, Ken
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (07) : 753 - 762
[44] Phase III study of apatinib in advanced gastric cancer: A randomized, double-blind, placebo-controlled trial.
Qin, Shukui
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[45] Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study
Uchimura, Naohisa
Taniguchi, Mitsutaka
Ariyoshi, Yu
Oka, Yasunori
Togo, Osamu
Uchiyama, Makoto
SLEEP MEDICINE, 2024, 122 : 27 - 34
[46] A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
Durgam, Suresh
Chen, Changzheng
Migliore, Raffaele
Prakash, Chandran
Edwards, John
Findling, Robert L.
PEDIATRIC DRUGS, 2018, 20 (04) : 353 - 363
[47] A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
Suresh Durgam
Changzheng Chen
Raffaele Migliore
Chandran Prakash
John Edwards
Robert L. Findling
Pediatric Drugs, 2018, 20 : 353 - 363
[48] Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study
Motoya, Satoshi
Watanabe, Kenji
Ogata, Haruhiko
Kanai, Takanori
Matsui, Toshiyuki
Suzuki, Yasuo
Shikamura, Mitsuhiro
Sugiura, Kenkichi
Oda, Kazunori
Hori, Tetsuharu
Araki, Takahiro
Watanabe, Mamoru
Hibi, Toshifumi
PLOS ONE, 2019, 14 (02):
[49] Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study
Lang, Jinghe
Yu, Qi
Zhang, Shulan
Li, Huajun
Gude, Kerstin
von Ludwig, Christiane
Ren, Xiaowei
Dong, Liying
JOURNAL OF WOMENS HEALTH, 2018, 27 (02) : 148 - 155
[50] Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study (FORWARD) of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Kuter, David J.
Piatek, Caroline, I
Saikali, Khalil
Dummer, Wolfgang
BLOOD, 2022, 140 : 2440 - 2441

← 1 2 3 4 5 →